_id

69131068ccc777a4e85d7e77

Ticker

LPTX

Name

Leap Therapeutics Inc

Exchange

NASDAQ

Address

47 Thorndike Street, Cambridge, MA, United States, 02141

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://www.leaptx.com

Description

Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops antibody therapies for the treatment of cancer. Its lead clinical stage drug candidate includes DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in various ongoing clinical trials for treating esophagogastric and gynecologic cancers, and colorectal cancer. The company also develops FL-501, a monoclonal antibody that inhibits GDF-15 protein that is in preclinical trial. It has an option and license agreement with Adimab, LLC and BeiGene, Ltd. to develop and commercialize DKN-01 in Asia (excluding Japan), Australia, and New Zealand. The company was formerly known as HealthCare Pharmaceuticals, Inc. and changed its name to Leap Therapeutics, Inc. in November 2015. Leap Therapeutics, Inc. was incorporated in 2011 and is based in Cambridge, Massachusetts.

Last Close

0.4375

Volume

933262

Current Price

2.05

Change

368.57142857142856

Last Updated

2025-11-11T10:31:04.490Z

Image

data:image/webp;base64,UklGRvAFAABXRUJQVlA4WAoAAAAQAAAAPwAAPwAAQUxQSAMDAAABkLXt//m2a/rV1imD2mfBXkBtG0ln17aTTjXnrbaNMZrt7dxG+ruuFPnn940IB24jKVKyvMc3UP0FRFljd+/kjIr6hqaG+oqMZC83Y0RYTctdYfsLBI1tHW2NgoL9oVxLTYIYOPrw84RdfRNL10USqUR0fWmit1OYy/d21CeDmUdqt+yLHCtT/lnaxXc3VR01muex1vmn3zAVvz2dbc0MttdUDR2rqLb7/zF15S/7+Ew9FdBihNWNP/6BVfHfmzlhOI36RUZk3w+sut97w+lUfm6EkBk3bfgDJuH7oTSOGUJITekFbunNDUzGjZslXGVXthyX3PqKSfn1VgnXTCnc0luYpLdKOMq6CS3t5leifL2ZztTeEVrY0AYm68ZINHPH5hra+x6T9kN/uM521GmCH5i8PwTW6tuwSZjGEE7Fbb/kf/EFCM/P+W5rculPf4Pw+0ma6ZZhyqNNjmGUt7rrK3BMncNQzvIcFPh0PwXjSYeXAr7sGxhfxTyEtPK+YDg/5WoaW9bLAfkvtHDjdmJIO9jeYX2g9ASnHJgEZXxvZuEyKIv5lcIboFyvO9kkBkXU0NguBUXS2twpA0XaDr850SQCvlwhuA78tMzCJeB2B9/uvUOh+50rB7jfs4wshKDjjsAcaeZ+BuRjtgZCPOk3ML6IUhBC3l1PwXjc7qXAgT8HxkyKgwJ991Y51KNb3LYEadO0J79B+PnouCnaot/55yA87fZBW2HGT4EwEcPYnnus674D8L3OSm2H3BVy9R353NUXpo120Dp0kHzui2IoyZ3HCefOLzfSmFpoZzklt4hyo4gNmru/3CzmUKig1Lgl5HL/jWKOGqW6g5M29J4I74aObzlWQ8qlh/eSaH/fe8Jo1ItVWmgtiborjKaJqKttGaly3cdj6KpYd1p7Hm2ZfUKtBXx5PNOSEWyngVTW1I3XKf6k/OH/P4raU1xNEBH1Hbx5uYKOnvGFa7clUsnta4vjPR2C7BQvez2Sdb8FO3hvbk1DW0dbQ03e3mCWOdXfCwEAVlA4IMYCAADQDwCdASpAAEAAPq1Gm0mmI6IhN/K8AMAViWwAuzmB2N4u/b+PX6ghH71+cVyxzgPMA5xPmA84D0LegB0j28bf3P/tJFXbFuh83SX5OX3UndJH1b8krZVW7gNvNqy8nLFHDSSAS17K2PJkj2LBt3OtLd395PTYZwfZYZ9EzA8L7voV2v2dYYAA/vypDyJS267t0z8/Z7tHS6DBdmZbecN6eIGNBYjdvk9sp5ssN4Iy9lDMx7ArH7t3sw6wdhsz5bEZH2x2ALuWRZILTYdZXzulDoJtT/lfx/z+5P9cH/T36AysvWEFT8GLkpn9lqYmkXJVwsKlfrBeenLlYRhuZFhaDInAOfPhNanfwtu8MRb01HoXjYfsx6/1qFL2BIcOeX6KrzdjXeP/zKpCzz3yfTffVQThExFmvWiDvfPi1V8V+Xr4BvYk/xq15z8YLqfiziiMyocatBoZ88YaabeNni411LOaD5arhqUtgk7RROpXMXe0PEh4dQNlS8zJGKMu0zpI1jGPMzFM1zK31PWULXSfEYkQqBlqmMk4M50yYgMFzy2S91NsE95r7VMkvLhoLYPeoViFFC2YgQJhxhg+y76LJUli1HNMI/LJ6GWlO4Iim4eRYiRvRixQbJhfPnEomqBLk+m0iS6wA+6F9x1F2Pbti9k73D1GM7caKLfQilD0TMC0KOovKnm37SHSvczfXi1w/vQ+/VK3L7ZYhL4JkBPhXDX/x216V+rnobI0mvfjBmPPHonLslBIMCgW4t9/3kiz9/R4bV5V7skCmkUdVp01Nu4ZxlqmiZmpYx7BN2cx6ZYGr/xeJviD3rUz30pZOAdSssu5kTwaynYF7LYdO4jE81T6eP0vrtVZv4HgG7Wcs+UqpCV/XWTsOE/7S29009pqBlV4NfiOrVXUNC1CfKZVgMpL4FmAPTHKONkvsbpu7ELaL7QAAA==

Ipo Date

2017-01-25T00:00:00.000Z

Market Cap

25963538

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

-

Sentiment Sources

0

Rating

3

Target Price

3

Strong Buy

0

Buy

0

Hold

1

Sell

0

Strong Sell

0

Current Quarter

2025-06-30

Revenue

0

Cost Of Revenue

-

Gross Profit

-

Operating Expenses

16881000

Operating Income

-16881000

Interest Expense

7000

Pretax Income

-16643000

Net Income

-16643000

Eps

-0.4015685470609118

Dividends Per Share

-

Shares Outstanding

41444979

Income Tax Expense

-

EBITDA

-16636000

Total Other Income Expense Net

-

Cash

18130000

Short Term Investments

-

Receivables

739000

Inventories

-

Total Current Assets

19161000

Property Plant Equipment

38000

Total Assets

20042000

Payables

7339000

Short Term Debt

39000

Long Term Debt

-

Total Liabilities

14325000

Equity

5717000

Depreciation

0

Change In Working Capital

552000

Cash From Operations

-14486000

Capital Expenditures

0

Cash From Investing

-

Cash From Financing

-119000

Net Change In Cash

-14583000

PE

-

PB

14.861327085884204

ROE

-291.11422074514604

ROA

-83.04061470911087

FCF

-14486000

Fcf Percent

-

Piotroski FScore

1

Health Score

21

Deep Value Investing Score

3

Defensive Investing Score

5.5

Dividend Investing Score

1.5

Economic Moat Investing Score

2.8

Garp Investing Score

0.5

Growth Investing Score

0.5

Momentum Investing Score

2

Net Net Investing Score

3.5

Quality Investing Score

1

Value Investing Score

2

Quarters > 0 > quarter

2025-06-30

Quarters > 0 > income Statement > revenue

0

Quarters > 0 > income Statement > cost Of Revenue

-

Quarters > 0 > income Statement > gross Profit

-

Quarters > 0 > income Statement > operating Expenses

16881000

Quarters > 0 > income Statement > operating Income

-16881000

Quarters > 0 > income Statement > interest Expense

7000

Quarters > 0 > income Statement > pretax Income

-16643000

Quarters > 0 > income Statement > net Income

-16643000

Quarters > 0 > income Statement > eps

-0.4015685470609118

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

41444979

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-16636000

Quarters > 0 > income Statement > total Other Income Expense Net

-

Quarters > 0 > balance Sheet > cash

18130000

Quarters > 0 > balance Sheet > short Term Investments

-

Quarters > 0 > balance Sheet > receivables

739000

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

19161000

Quarters > 0 > balance Sheet > property Plant Equipment

38000

Quarters > 0 > balance Sheet > total Assets

20042000

Quarters > 0 > balance Sheet > payables

7339000

Quarters > 0 > balance Sheet > short Term Debt

39000

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

14325000

Quarters > 0 > balance Sheet > equity

5717000

Quarters > 0 > cash Flow > net Income

-16643000

Quarters > 0 > cash Flow > depreciation

0

Quarters > 0 > cash Flow > change In Working Capital

552000

Quarters > 0 > cash Flow > cash From Operations

-14486000

Quarters > 0 > cash Flow > capital Expenditures

0

Quarters > 0 > cash Flow > cash From Investing

-

Quarters > 0 > cash Flow > cash From Financing

-119000

Quarters > 0 > cash Flow > net Change In Cash

-14583000

Quarters > 0 > ratios > PE

-0.4015685470609118

Quarters > 0 > ratios > PB

14.861327085884204

Quarters > 0 > ratios > ROE

-291.11422074514604

Quarters > 0 > ratios > ROA

-83.04061470911087

Quarters > 0 > ratios > FCF

-14486000

Quarters > 0 > ratios > Piotroski FScore

1

Quarters > 0 > ratios > fcf Percent

-

Quarters > 0 > health Score

21

Quarters > 1 > quarter

2025-03-31

Quarters > 1 > income Statement > revenue

0

Quarters > 1 > income Statement > cost Of Revenue

-

Quarters > 1 > income Statement > gross Profit

-

Quarters > 1 > income Statement > operating Expenses

15917000

Quarters > 1 > income Statement > operating Income

-15917000

Quarters > 1 > income Statement > interest Expense

6000

Quarters > 1 > income Statement > pretax Income

-15435000

Quarters > 1 > income Statement > net Income

-15435000

Quarters > 1 > income Statement > eps

-0.37401050776887795

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

41268894

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

-15917000

Quarters > 1 > income Statement > total Other Income Expense Net

-

Quarters > 1 > balance Sheet > cash

32713000

Quarters > 1 > balance Sheet > short Term Investments

-

Quarters > 1 > balance Sheet > receivables

711000

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

33870000

Quarters > 1 > balance Sheet > property Plant Equipment

152000

Quarters > 1 > balance Sheet > total Assets

34879000

Quarters > 1 > balance Sheet > payables

6357000

Quarters > 1 > balance Sheet > short Term Debt

154000

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

14039000

Quarters > 1 > balance Sheet > equity

20840000

Quarters > 1 > cash Flow > net Income

-15435000

Quarters > 1 > cash Flow > depreciation

0

Quarters > 1 > cash Flow > change In Working Capital

-363000

Quarters > 1 > cash Flow > cash From Operations

-14480000

Quarters > 1 > cash Flow > capital Expenditures

0

Quarters > 1 > cash Flow > cash From Investing

-

Quarters > 1 > cash Flow > cash From Financing

-61000

Quarters > 1 > cash Flow > net Change In Cash

-14536000

Quarters > 1 > ratios > PE

-0.37401050776887795

Quarters > 1 > ratios > PB

4.059560110364683

Quarters > 1 > ratios > ROE

-74.06429942418427

Quarters > 1 > ratios > ROA

-44.25298890449841

Quarters > 1 > ratios > FCF

-14480000

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-

Quarters > 1 > health Score

34

Quarters > 2 > quarter

2024-12-31

Quarters > 2 > income Statement > revenue

10000

Quarters > 2 > income Statement > cost Of Revenue

5000

Quarters > 2 > income Statement > gross Profit

5000

Quarters > 2 > income Statement > operating Expenses

16125000

Quarters > 2 > income Statement > operating Income

-16125000

Quarters > 2 > income Statement > interest Expense

-

Quarters > 2 > income Statement > pretax Income

-15554000

Quarters > 2 > income Statement > net Income

-15431000

Quarters > 2 > income Statement > eps

-0.3740665124245304

Quarters > 2 > income Statement > dividends Per Share

-234000

Quarters > 2 > income Statement > shares Outstanding

41252022

Quarters > 2 > income Statement > income Tax Expense

-123000

Quarters > 2 > income Statement > EBITDA

-12534000

Quarters > 2 > income Statement > total Other Income Expense Net

-

Quarters > 2 > balance Sheet > cash

47249000

Quarters > 2 > balance Sheet > short Term Investments

-

Quarters > 2 > balance Sheet > receivables

704000

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

48039000

Quarters > 2 > balance Sheet > property Plant Equipment

262000

Quarters > 2 > balance Sheet > total Assets

49124000

Quarters > 2 > balance Sheet > payables

4743000

Quarters > 2 > balance Sheet > short Term Debt

266000

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

14076000

Quarters > 2 > balance Sheet > equity

35048000

Quarters > 2 > cash Flow > net Income

-15431000

Quarters > 2 > cash Flow > depreciation

0

Quarters > 2 > cash Flow > change In Working Capital

-2067000

Quarters > 2 > cash Flow > cash From Operations

-15512000

Quarters > 2 > cash Flow > capital Expenditures

0

Quarters > 2 > cash Flow > cash From Investing

-

Quarters > 2 > cash Flow > cash From Financing

104000

Quarters > 2 > cash Flow > net Change In Cash

-15574000

Quarters > 2 > ratios > PE

-0.3740665124245304

Quarters > 2 > ratios > PB

2.412880766377539

Quarters > 2 > ratios > ROE

-44.02818991097923

Quarters > 2 > ratios > ROA

-31.41234427163912

Quarters > 2 > ratios > FCF

-15512000

Quarters > 2 > ratios > Piotroski FScore

0

Quarters > 2 > ratios > fcf Percent

-1551.2

Quarters > 2 > health Score

34

Quarters > 3 > quarter

2024-09-30

Quarters > 3 > income Statement > revenue

0

Quarters > 3 > income Statement > cost Of Revenue

-

Quarters > 3 > income Statement > gross Profit

-

Quarters > 3 > income Statement > operating Expenses

17855000

Quarters > 3 > income Statement > operating Income

-17855000

Quarters > 3 > income Statement > interest Expense

-

Quarters > 3 > income Statement > pretax Income

-17468000

Quarters > 3 > income Statement > net Income

-18176000

Quarters > 3 > income Statement > eps

-0.44106185933829706

Quarters > 3 > income Statement > dividends Per Share

-234000

Quarters > 3 > income Statement > shares Outstanding

41209639

Quarters > 3 > income Statement > income Tax Expense

708000

Quarters > 3 > income Statement > EBITDA

-17855000

Quarters > 3 > income Statement > total Other Income Expense Net

-

Quarters > 3 > balance Sheet > cash

62823000

Quarters > 3 > balance Sheet > short Term Investments

-

Quarters > 3 > balance Sheet > receivables

780000

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

63812000

Quarters > 3 > balance Sheet > property Plant Equipment

370000

Quarters > 3 > balance Sheet > total Assets

65047000

Quarters > 3 > balance Sheet > payables

5946000

Quarters > 3 > balance Sheet > short Term Debt

752000

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

16093000

Quarters > 3 > balance Sheet > equity

48954000

Quarters > 3 > cash Flow > net Income

-18176000

Quarters > 3 > cash Flow > depreciation

-202000

Quarters > 3 > cash Flow > change In Working Capital

-2128000

Quarters > 3 > cash Flow > cash From Operations

-15600000

Quarters > 3 > cash Flow > capital Expenditures

0

Quarters > 3 > cash Flow > cash From Investing

-

Quarters > 3 > cash Flow > cash From Financing

-66000

Quarters > 3 > cash Flow > net Change In Cash

-15656000

Quarters > 3 > ratios > PE

-0.44106185933829706

Quarters > 3 > ratios > PB

1.7256967755443886

Quarters > 3 > ratios > ROE

-37.12873309637619

Quarters > 3 > ratios > ROA

-27.942872077113474

Quarters > 3 > ratios > FCF

-15600000

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-

Quarters > 3 > health Score

43

Valuation > metrics > PE

-0.4015685470609118

Valuation > metrics > PB

14.861327085884204

Valuation > final Score

20

Valuation > verdict

395.4% Overvalued

Profitability > metrics > ROE

-291.11422074514604

Profitability > metrics > ROA

-86.85872344867178

Profitability > final Score

15

Profitability > verdict

Weak

Risk > metrics > Debt Equity

2.505684799720133

Risk > metrics > Interest Coverage

-2411.5714285714284

Risk > final Score

-9628

Risk > verdict

High

Liquidity > metrics > Current Ratio

2.5970452697207915

Liquidity > metrics > Quick Ratio

2.5970452697207915

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

39.40439889635317

Prev Valuations > 1

80

Prev Valuations > 2

80

Prev Profitabilities > 0

15

Prev Profitabilities > 1

0

Prev Profitabilities > 2

15

Prev Risks > 0

-10563

Prev Risks > 1

39

Prev Risks > 2

-125

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2026-01-20T22:09:19.150Z